Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits QuantWave's Forecast Target with Profit of 22.51%

August 08, 2023
ELI LILLY AND COMPANY stock recently reached the price target forecasted by QuantWave on May 24, 2023. The forecast indicated a long position with a price of $419.74 at the time of the signal. On August 8, 2023, the stock reached $514.21, resulting in a profit of 22.51% for investors who followed the prediction.

This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The successful forecast for ELI LILLY AND COMPANY demonstrates the platform's ability to provide valuable insights for investors seeking profitable opportunities in the market.

The stock's movement may have been influenced by various factors such as company performance, market trends, economic indicators, and investor sentiment. QuantWave's advanced data analysis and machine learning algorithms enable users to make informed decisions based on comprehensive market analysis.

QuantWave offers a user-friendly automated forecasting platform where investors can access predictions for a wide range of stocks, presenting opportunities for potential profits. For investors looking to enhance their understanding of the investment strategy behind QuantWave, exploring the educational resources of QuantSchool is recommended. QuantSchool provides a professional investment framework that reveals the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

GOOGLJuly 28, 2023ALPHABET INC. Hits QuantWave's Price Target Forecast with 26.24% Profit  ~1 min.

ALPHABET INC. (NASDAQ: GOOGL) investors reaped the rewards as the stock reached the price target forecasted by QuantWave, generating a profit of 26.24%....

BTC-USDDecember 3, 2023BITCOIN USD Hits Forecast Price Target with 47.95% Profit  ~1 min.

QuantWave, a leading automated forecasting platform, achieved a significant milestone as its price target forecast for BITCOIN USD was successfully reached on December 3, 2023....

NOCAugust 20, 2024QuantWave Forecast Hits Target for NORTHROP GRUMMAN CORPORATION with 7.64% Profit  ~1 min.

Northrop Grumman Corporation's stock price successfully reached the forecasted target of 499.27 $ on August 20, 2024, generating a profit of 7....

CABOMay 2, 2025QuantWave Successfully Forecasts 43.49% Profit on CABLE ONE, INC. Stock  ~1 min.

QuantWave, a leading automated forecasting platform, achieved a significant milestone with its accurate prediction for the stock of CABLE ONE, INC....

DOWApril 3, 2025QuantWave Achieves 13.02% Profit with DOW INC. Price Target Forecast  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target forecast for DOW INC. with a profit of 13.02%. The forecast signal was issued on March 21, 2025, when the price was at 36....